v3.22.1
Stockholders' Deficit - Summary of Stock Option Activity (Detail) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jan. 29, 2022
Jan. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]    
Shares, Outstanding, Beginning balance 855,000  
Shares, Granted 286,000 855,000
Shares, Outstanding, Ending balance 1,141,000 855,000
Shares, Vested and expected to vest 1,141,000  
Shares, Exercisable 854,000  
Shares, Non-vested 287,000  
Wtd. Avg. Exercise Price, Outstanding, Beginning balance $ 1.74  
Wtd. Avg. Exercise Price, Granted 2.53  
Wtd. Avg. Exercise Price, Outstanding, Ending balance 1.88 $ 1.74
Wtd. Avg. Exercise Price, Vested and expected to vest 1.88  
Wtd. Avg. Exercise Price, Exercisable 1.75  
Wtd. Avg. Exercise Price, Non-vested $ 2.29  
Wtd. Avg. Remaining Contractual Life, Outstanding 4 years  
Wtd. Avg. Remaining Contractual Life, Vested and expected to vest 4 years  
Wtd. Avg. Remaining Contractual Life, Exercisable 3 years 10 months 2 days  
Wtd. Avg. Remaining Contractual Life, Non-vested 4 years 5 months 23 days  
Aggregate Intrinsic Value, Outstanding $ 565  
Aggregate Intrinsic Value, Vested and expected to vest 565  
Aggregate Intrinsic Value, Exercisable 512  
Aggregate Intrinsic Value, Non-vested $ 53